Used in research for the treatment of Rett syndrome, a rare neurodevelopmental disorder. Acts as a positive allosteric modulator of the GABAA receptor, enhancing inhibitory neurotransmission in the brain. Shows potential to improve respiratory, motor, and behavioral symptoms associated with the condition. Currently under investigation in preclinical and early clinical studies to evaluate efficacy and safety. Not approved for general medical use.